Inventaire - your friends and communities are your best library

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome

author

Donna Niedzwiecki

Heinz-Josef Lenz

Hanna K Sanoff

Federico Innocenti

published in: Journal of Clinical Oncology

date of publication: 2019-03-13

main subject: microsatellite, colorectal cancer, colorectal carcinoma, mutational analysis

Cites articles 14

Date

Title

Authors

2017-06-01

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

Eileen M. O'Reilly, Heinz-Josef Lenz, Jeffrey A Meyerhardt, Federico Innocenti
2017-04-29

Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study
2017-08-01

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials

Dirk Arnold, Marc Peeters, Jean-Pierre Pignon
2017-04-03

Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming

Sendurai A. Mani, Lin Tian, Kuanwei Sheng, Chenghang Zong
2017-03-01

Colorectal cancer statistics, 2017.
2016-10-10

Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials

Josep Tabernero Caturla, Sabine Tejpar, Fortunato Ciardiello, Heinz-Josef Lenz
2016-06-07

Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer

Scott Kopetz
2016-04-14

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

Gad Getz, Eric Lander, Mara Rosenberg, Yin Cao, Kentaro Inamura, Stacey Gabriel, Edward Giovannucci, Jeffrey A Meyerhardt, Charles S. Fuchs, Levi A Garraway, Katsuhiko Nosho, Shuji Ogino, Kosuke Mima, Jonathan A Nowak, Reiko Nishihara, Mai Yamauchi, Zhi Rong Qian, Yasutaka Sukawa, Marios Giannakis, Xinmeng Jasmine Mu, Sachet A Shukla, Samira Bahl, Chip Stewart, Eliezer Van Allen, Kimmie Ng
2016-03-01

Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability

Pierre Laurent-Puig, Michael R. Speicher, Jérôme Galon, Franck Pagès, Anna C Obenauf, David Tougeron, Patrick Bruneval, Bernhard Mlecnik, Zlatko Trajanoski, Gabriela Bindea, Viia Valge-Archer, Amélie M Bilocq, Helen K Angell, Amos Kirilovsky, Pauline Maby, Mihaela Angelova, Lucie Lafontaine, Tessa Fredriksen, Mohamad Hamieh, Jean Jacques Tuech, Jean-Christophe Sabourin, Florence Le Pessot, Jacques Mauillon, Arash Rafii Tabrizi, Jean-Baptiste Latouche
2015-08-27

The colorectal cancer immune paradox revisited

Mihaela Angelova, Hubert Hackl, Pornpimol Charoentong
2015-08-18

Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial).
2014

Next generation MUT-MAP, a high-sensitivity high-throughput microfluidics chip-based mutation analysis panel
2013-07-01

Defective mismatch repair and benefit from bevacizumab for colon cancer: findings from NSABP C-08.

Greg Yothers, Soonmyung Paik
2013-02-02

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

Sabine Tejpar, George Fountzilas

Article - wd:Q92327872

Welcome to Inventaire

the library of your friends and communities

learn more